Literature DB >> 2116907

Proteoglycans synthesized in vitro by nude and normal mouse peritoneal macrophages.

V L Petricevich1, Y M Michelacci.   

Abstract

Peritoneal macrophages from nude mice were found to be functionally similar to 'activated' macrophages from normal mice. The objective of the present study was to characterize the proteoglycans synthesized and secreted in vitro by peritoneal macrophages isolated from nude and normal Balb/c mice and to investigate the relationship between macrophage 'activation' and changes in the proteoglycan patterns. Macrophages obtained by peritoneal lavage were seeded in Petri dishes. After 2 h incubation at 37 degrees C, the adherent cells (macrophages) were exposed to [35S]sulphate for the biosynthetic labelling of proteoglycans. After incubation, the cell and medium fractions were collected and analysed for proteoglycans and glycosaminoglycans. The glycosaminoglycans were identified and characterized by a combination of agarose gel electrophoresis and enzymatic degradation with specific mucopolysaccharidases. It was shown that 3/4 of the total 35S-labelled glycosaminoglycans were in the extracellular compartment after 24-48 h. The macrophages synthesized dermatan sulphate (68%), chondroitin sulphate (7%) and heparan sulphate (25%). Both cell and medium fractions of normal and nude mouse macrophages contained glycosaminoglycans with the same ratios, although the nude mouse macrophages synthesized 2-fold less glycosaminoglycans than the normal mouse macrophages. Lower levels of 35S-proteoglycans were also obtained from in vitro 'activated' macrophages, but the ratios of dermatan sulphate:chondroitin sulphate: heparan sulphate were altered in these cells as compared to the control. Furthermore, all the 35S-macromolecules found in the extracellular compartment of nude and normal control cells were of proteoglycan nature, in contrast to the medium fractions of 'activated' macrophages, which contain both intact proteoglycans and 'free' glycosaminoglycan chains. These results indicate that, at least as regards the proteoglycans and glycosaminoglycans, the nude mouse macrophages are not identical to the 'activated' macrophages from normal mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116907     DOI: 10.1016/0167-4889(90)90005-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.

Authors:  Lubica Rauova; Jessica D Hirsch; Teshell K Greene; Li Zhai; Vincent M Hayes; M Anna Kowalska; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

2.  Relevance of synovial fluid chondroitin sulphate as a biomarker to monitor polo pony joints.

Authors:  Raquel Y A Baccarin; Luciane Rasera; Thaís S L Machado; Yara M Michelacci
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

Review 3.  Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Authors:  L Rauova; G Arepally; S E McKenzie; B A Konkle; D B Cines; M Poncz
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

4.  Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia.

Authors:  Jing Dai; Daria Madeeva; Vincent Hayes; Hyun Sook Ahn; Valerie Tutwiler; Gowthami M Arepally; Douglas B Cines; Mortimer Poncz; Lubica Rauova
Journal:  Blood       Date:  2018-06-18       Impact factor: 25.476

5.  Proteoglycan synthesis by human corneal explants submitted to laser in situ keratomileusis (LASIK).

Authors:  Suy Anne Reboucas Martins; Mauro Q Campos; Benedicto C Vidal; Alessandra G A Berto; Jair A K Aguiar; Yara M Michelacci
Journal:  Mol Vis       Date:  2007-02-01       Impact factor: 2.367

Review 6.  Biological functions of iduronic acid in chondroitin/dermatan sulfate.

Authors:  Martin A Thelin; Barbara Bartolini; Jakob Axelsson; Renata Gustafsson; Emil Tykesson; Edgar Pera; Åke Oldberg; Marco Maccarana; Anders Malmstrom
Journal:  FEBS J       Date:  2013-03-28       Impact factor: 5.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.